These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24373070)

  • 21. Interferon, cortisone, and antivirals in the treatment of chronic viral hepatitis: a review of 30 years of therapy.
    Malaguarnera M; Restuccia S; Motta M; Ruello P; Trovato BA; Pistone G
    Pharmacotherapy; 1997; 17(5):998-1005. PubMed ID: 9324188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment and reversibility of liver fibrosis in viral hepatitis].
    Vallet-Pichard A; Pol S; Mallet V
    Rev Prat; 2011 Jan; 61(1):39-43. PubMed ID: 21452541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Viral hepatitis--trends].
    Manciuc C; Dorobăţ C; Filip-Ciubotaru FM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):327-31. PubMed ID: 20700962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The ABC of viral hepatitis].
    Van Bambeke F
    J Pharm Belg; 2008 Mar; 63(1):15-20. PubMed ID: 18479077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing epidemiology of liver disease in HIV patients.
    Soriano V; Barreiro P; Sherman KE
    AIDS Rev; 2013; 15(1):25-31. PubMed ID: 23449226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining optimal therapeutic outcomes in chronic hepatitis.
    Lisker-Melman M; Sayuk GS
    Arch Med Res; 2007 Aug; 38(6):652-60. PubMed ID: 17613357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis A, B, C, D, E, G: an update.
    Hall GF
    Ethn Dis; 2007; 17(2 Suppl 2):S2-40-5. PubMed ID: 17684813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.
    Fleurence RL; Collins FS
    JAMA; 2023 Apr; 329(15):1251-1252. PubMed ID: 36892976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on viral hepatitis: 2006.
    Tan J; Lok AS
    Curr Opin Gastroenterol; 2007 May; 23(3):263-7. PubMed ID: 17414841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis--changing trends.
    Sood A; Singh P; Midha V
    J Assoc Physicians India; 1998 May; 46(5):454-9. PubMed ID: 11273290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral hepatitis in the elderly.
    Carrion AF; Martin P
    Am J Gastroenterol; 2012 May; 107(5):691-7. PubMed ID: 22290404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global elimination of hepatitis C virus by 2030: why not?
    Dore GJ; Martinello M; Alavi M; Grebely J
    Nat Med; 2020 Feb; 26(2):157-160. PubMed ID: 32047317
    [No Abstract]   [Full Text] [Related]  

  • 33. The importance of rapid viral suppression in the era of directly acting antiviral therapy for hepatitis C virus.
    Jenkins ET; Jensen DM
    Infect Dis Clin North Am; 2012 Dec; 26(4):879-91. PubMed ID: 23083821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEDICINE. Global control of hepatitis C virus.
    Cox AL
    Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
    Feld JJ
    Gastroenterology; 2012 May; 142(6):1356-9. PubMed ID: 22537443
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of chronic viral hepatitis: a critical view.
    Rizzetto M
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):781-93. PubMed ID: 10730571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Established and emerging therapies for the treatment of viral hepatitis.
    Forton D; Karayiannis P
    Dig Dis; 2006; 24(1-2):160-73. PubMed ID: 16699274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.